Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Immix Biopharma, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −2 vs. Q3 2024
- Shares held
- 2.87M
- −1.22M (−29.9%) vs. Q3 2024
- Total value
- $6.32M
- +$212.8K (+3.5%) vs. Q3 2024
- New holders
- 5
- 3 more added
- Sold out
- 7
- 6 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 109 | $579.6M |
| Q1 2026 | 77 | $246.6M |
| Q4 2025 | 67 | $127.5M |
| Q3 2025 | 31 | $5.78M |
| Q2 2025 | 23 | $4.68M |
| Q1 2025 | 22 | $4.90M |
| Q4 2024 | 23 | $6.32M |
| Q3 2024 | 25 | $6.10M |
| Q2 2024 | 31 | $8.77M |
| Q1 2024 | 35 | $15.7M |
| Q4 2023 | 28 | $5.32M |
| Q3 2023 | 16 | $1.39M |
| Q2 2023 | 18 | $1.75M |
| Q1 2023 | 12 | $729.8K |
| Q4 2022 | 18 | $1.01M |
| Q3 2022 | 12 | $406.0K |
| Q2 2022 | 7 | $475.0K |
| Q1 2022 | 8 | $352.0K |
| Q4 2021 | 11 | $5.47M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Immix Biopharma, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 22 | $0 | 0.00% | +22 | New |
| JPMorgan Chase & Co | 38 | $84 | 0.00% | +38 | New |
| Bank of America Corp | 114 | $251 | 0.00% | −1−0.9% | Reduced |
| Tower Research Capital LLC (TRC) | 181 | $398 | 0.00% | −2,929−94.2% | Reduced |
| Wells Fargo & Company | 330 | $726 | 0.00% | 00.0% | Unchanged |
| Tortoise Investment Management, LLC | 1,300 | $2.86K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,000 | $4.00K | 0.00% | −82,000−97.6% | Reduced |
| Colony Group, LLC | 11,900 | $26.2K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 14,076 | $31.0K | 0.00% | +73+0.5% | Added |
| UBS Group AG | 14,208 | $31.3K | 0.00% | +8,062+131.2% | Added |
| SBI Securities Co., Ltd. | 17,500 | $38.5K | 0.00% | +17,500 | New |
| Jane Street Group, LLC | 17,523 | $38.6K | 0.00% | +17,523 | New |
| Commonwealth Equity Services, LLC | 25,860 | $57.0K | 0.00% | −220−0.8% | Reduced |
| FNY Investment Advisers, LLC | 28,750 | $63.0K | 0.03% | +28,750 | New |
| Private Advisor Group, LLC | 31,225 | $68.7K | 0.00% | −3,100−9.0% | Reduced |
| Tocqueville Asset Management L.P. | 38,300 | $84.3K | 0.00% | −5,000−11.5% | Reduced |
| Northern Trust Corp | 38,914 | $85.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 42,960 | $94.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 91,051 | $200.3K | 0.00% | +6,738+8.0% | Added |
| Geode Capital Management, LLC | 150,082 | $330.2K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 698,537 | $1.54M | 0.00% | 00.0% | Unchanged |
| Cable Car Capital LLC | 796,100 | $1.75M | 0.13% | 00.0% | Unchanged |
| Bleichroeder LP | 850,000 | $1.87M | 0.47% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −1,123,663−100.0% | Sold out |
| Invst, LLC | 0 | $0 | 0.00% | −27,000−100.0% | Sold out |
| Tritonpoint Wealth, LLC | 0 | $0 | 0.00% | −24,526−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −21,521−100.0% | Sold out |
| Old National Bancorp | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,492−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −950−100.0% | Sold out |